PRCTPROCEPT BioRobotics Corp

Nasdaq procept-biorobotics.com


$ 81.96 $ 0.88 (1.08 %)    

Monday, 16-Sep-2024 15:59:55 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 81.99
$ 82.97
$ 75.95 x 100
-- x --
$ 81.30 - $ 83.50
$ 24.83 - $ 85.81
513,291
na
4.26B
$ 1.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 07-28-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 03-22-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-procept-biorobotics-raises-price-target-to-99

TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price target from $75...

 jim-cramer-says-this-retailer-yields-3-which-is-quite-good

Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. "

 truist-securities-maintains-buy-on-procept-biorobotics-raises-price-target-to-95

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price targe...

 b-of-a-securities-maintains-buy-on-procept-biorobotics-raises-price-target-to-94

B of A Securities analyst Craig Bijou maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price target fro...

 wells-fargo-maintains-overweight-on-procept-biorobotics-raises-price-target-to-69

Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price targe...

 truist-securities-reiterates-buy-on-procept-biorobotics-lowers-price-target-to-74

Truist Securities analyst Richard Newitter reiterates PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price targ...

 procept-biorobotics-q2-2024-gaap-eps-050-beats-052-estimate-sales-53353m-beat-50164m-estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $...

 truist-securities-maintains-buy-on-procept-biorobotics-raises-price-target-to-79

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price targe...

 procept-biorobotics-announces-new-cpt-category-i-code-from-the-ama-for-aquablation-therapy-to-treat-benign-prostatic-hyperplasia

PROCEPT BioRobotics® Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused on advancing patien...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION